EUROIMMUN introduces CE marked SARS-CoV-2 antigen ELISA test
The novel test facilitates the semi-quantitative automatable detection of the SARS-CoV-2 nucleocapsid protein on a large scale
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Dec 20
The novel test facilitates the semi-quantitative automatable detection of the SARS-CoV-2 nucleocapsid protein on a large scale
17 Dec 20
Available today, Health Harmony app enables employers, schools, payers, providers, and healthcare systems to help their constituents manage…
17 Dec 20
Ten-minute tests manufactured in the heart of the Bay Area to help vulnerable communities
16 Dec 20
SARS-CoV-2 IgG II Quant antibody blood test offers better understanding of a person's immune response to a Covid-19…
16 Dec 20
The cobas PIK3CA mutation test has been designed for the detection of 17 mutations in the PIK3CA gene
16 Dec 20
To facilitate the delivery of the BinaxNOW test to the home and the guided collection and testing process,…
16 Dec 20
The CE Mark confirms that the Company's Maverick series products meet the requirements of the European In-Vitro Diagnostic…
14 Dec 20
The BMJ's chief statistical advisor cited multiple concerns about the inaccuracy of lateral flow testing for asymptomatic people
14 Dec 20
The Elecsys SARS-CoV-2 antigen test facilitates the in vitro qualitative detection of the nucleocapsid antigen of SARS CoV…
14 Dec 20
The SalivaDirect is allowed for use at limited laboratories, designated by the Yale School of Public Health